Third Rock Ventures GP III, L.P.'s Net Worth

$769 Million

Estimate Recalculated Feb 22, 2024 04:42PM EST

Who is Third Rock Ventures GP III, L.P.?

Third Rock Ventures GP III, L.P. has an estimated net worth of $769 Million. This is based on reported shares across multiple companies, which include Fulcrum Therapeutics, Inc., Revolution Medicines, Inc., PLIANT THERAPEUTICS, INC., Editas Medicine, Inc., Jounce Therapeutics, Inc., Voyager Therapeutics, Inc., Nurix Therapeutics, Inc., Global Blood Therapeutics, Inc., Relay Therapeutics, Inc., MyoKardia Inc, Neon Therapeutics, Inc., and Decibel Therapeutics, Inc..

SEC CIK

Third Rock Ventures GP III, L.P.'s CIK is 0001637300

Past Insider Trading and Trends

2020 was Third Rock Ventures GP III, L.P.'s most active year for acquiring shares with 11 total transactions. Third Rock Ventures GP III, L.P.'s most active month to acquire stocks was the month of June. 2021 was Third Rock Ventures GP III, L.P.'s most active year for disposing of shares, totalling 18 transactions. Third Rock Ventures GP III, L.P.'s most active month to dispose stocks was the month of December. 2019 saw Third Rock Ventures GP III, L.P. paying a total of $1,300,000.00 for 5,676,488 shares, this is the most they've acquired in one year. In 2021 Third Rock Ventures GP III, L.P. cashed out on 13,022,394 shares for a total of $243,054,711.61, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Revolution Medicines, Inc. (RVMD) Snapshot price: $29.84

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-7.60%
-419.90K
$20.25
-$8,502,995.25
5.1M
Jun 8
Form 4
-21.36%
-1.50M
5.52M
Feb 24
Form 4
-12.46%
-1.00M
7.02M
Dec 2
Form 4
-11.08%
-1.00M
8.02M
Sep 9
Form 4
+2,560.14%
10.52M
10.93M
Feb 18
Form 3
0
0
No matching records found

PLIANT THERAPEUTICS, INC. (PLRX) Snapshot price: $16.11

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-52.09%
-2.00M
1.84M
Nov 29
Form 4
-34.25%
-2.00M
3.84M
Scheduled
Sep 20
Form 4
+2,750.00%
7.69M
7.97M
Jun 5
Form 3
0
0
No matching records found

Editas Medicine, Inc. (EDIT) Snapshot price: $7.15

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-16.11%
-750.00K
3.91M
Aug 16
Form 4
4.66M
4.66M
Feb 8
Form 3
0
0
No matching records found

Jounce Therapeutics, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-62.32%
-1.90M
$8.38
-$15,922,000.00
1.15M
Nov 12
Form 4
+2,350.00%
12.74M
13.28M
Feb 1
Form 3
0
0
No matching records found

Nurix Therapeutics, Inc. (NRIX) Snapshot price: $8.54

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-24.08%
-1.09M
3.42M
Scheduled
May 6
Form 4
-16.86%
-914.22K
4.51M
Feb 4
Form 4
5.42M
5.42M
Jul 28
Form 3
0
0
No matching records found